Protherics PLC announces Holding(s) in Company
October 28 2008 - 2:47PM
Marketwired
Protherics PLC
Notification of Major Interest in Shares
London, UK; Brentwood, TN, US; 28 October 2008 - Protherics PLC
("Protherics" or the "Company"), the international biopharmaceutical
company focused on critical care and cancer, announces that the
following notification of interest in the ordinary share capital of the
Company was received today from Aviva plc.
1. Reason for the notification (please tick the
appropriate box or boxes)
An acquisition or disposal voting rights
An acquisition or disposal of financial instruments
which may result in the acquisition of shares already
issued to which voting rights are attached
An event changing the breakdown of voting rights
Other (please specify): INCREASE IN NUMBER OF VOTING X
SHARES IN ISSUE
2. Full name of person(s) subject to the Aviva plc & its
notification obligation: subsidiaries
3. Full name of shareholder(s) (if different from Registered Holder:
2.):
BNY Norwich Union
Nominees Limited
6,033,442*
Chase GA Group
Nominees Limited
19,592,672*
Chase Nominees
Limited
881,559*
CUIM Nominee
Limited
4,416,028*
Vidacos Nominees
Limited
65,125*
*denotes direct
interest
BNP Paribas
- London
636,429
Chase Nominees
Limited
3,171,774
State Street
Nominees Limited
9,428,137 Vidacos Nominees
Limited
1,746,000
4. Date of the transaction (and date on which the 27 October 2008
threshold is crossed or reached if different):
5. Date on which issuer notified: 28 October 2008
6. Threshold(s) that is/are crossed or reached: 9% to 8% Change
at Direct Interest
level
7. Notified details:
A: Voting rights attached to shares
Class/type Situation previous Resulting situation after the
of shares to the Triggering triggering transaction
transaction
if possible
using the Number of Number of Number of Number of voting
ISIN CODE Shares Voting shares rights
Rights
Direct Direct Indirect
Ordinary
Shares 46,722,061 46,722,061 30,988,826 30,988,826 14,982,340
GB0007029209
Resulting situation after
the triggering transaction
%of voting rights
Direct Indirect
8.84% 4.28%
B: Financial Instruments
Resulting situation after the triggering transaction
Type of Expiration Exercise/ Number of voting rights that % of
financial date Conversion may be acquired if the voting
instrument Period/ instrument is exercised/ rights
Date converted.
N/A
Total (A+B)
Number of voting rights % of voting rights
45,971,166 13.12%
8. Chain of controlled undertakings through which the voting rights and
/or the financial instruments are effectively held, if applicable :
The voting rights are managed and controlled by Aviva Investors Global
Services Limited, with the following chain of controlled undertakings:-
Aviva Investors Global Services Limited:
- Aviva plc (Parent Company)
- Aviva Group Holdings Limited (wholly owned subsidiary of Aviva plc)
- Aviva Investors Holdings Limited (wholly owned subsidiary of Aviva
Group Holdings Limited)
- Aviva Investors Global Services Limited (wholly owned subsidiary of
Aviva Investors Holdings Limited)
Proxy Voting:
9. Name of the proxy holder: See Section 3
10. Number of voting rights proxy holder will cease to
hold:
11. Date on which proxy holder will cease to hold voting
rights:
12. Additional Figures are based on a revised total number of
information: voting rights of 340,427,481
/ Ends /
For further information please contact:
Protherics
Nick Staples, Director of Corporate Affairs +44 (0) 7919 480510
Julie Vickers, Company Secretary +44 (0)1928 518010
Financial Dynamics - press enquiries
London: Ben Atwell, Lara Mott +44 (0) 20 7831 3113
New York: John Capodanno +1 212 850 5600
Or visit www.protherics.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
Contacts: RNS Customer Services 0044-207797-4400 Email Contact
http://www.rns.com
Protherics (NASDAQ:PTIL)
Historical Stock Chart
From May 2024 to Jun 2024
Protherics (NASDAQ:PTIL)
Historical Stock Chart
From Jun 2023 to Jun 2024
